CJC-1295 + Ipamorelin
GHRH + GHRP Combination
Research Highlights
Research category: Performance & Longevity Research Blend
2 literature references — see Research tab
Blend Composition
Lyophilized powder — reconstitution with bacteriostatic water or a suitable solvent is required prior to in-vitro experimental use. BAC Water is available separately in our Solvents category.
CJC-1295 + Ipamorelin is a research co-formulation combining a GHRH analogue with a selective GHS-R agonist. This combination is studied for its complementary mechanisms on GH pulsatile release12 and IGF-1 axis signalling1. The pairing provides researchers a model for studying dual-pathway GH axis modulation2.
Third-Party Verified
Certificates of Analysis
Every batch is independently tested. COAs are issued per lot — all vial sizes from the same lot share one certificate. The batch is tested on a representative sample prior to dispensing.